Skip to content

CRON

Cronos Group, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA

$3.25
+1.25%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue225.2M149.2M117.6M87.2M86.7M
Cost of Revenue143.8M87.5M92.4M75.3M71.3M
Gross Profit81.4M61.7M25.2M11.9M15.4M
Operating Expenses
R&D Expense5.3M4.4M4.2M5.8M13.1M
SG&A Expense67.0M63.8M76.8M80.9M100.7M
General & Admin Expense42.8M42.0M55.2M58.2M82.7M
Selling & Marketing Expense24.3M21.8M21.6M22.7M18.0M
Other Expenses(3.6M)11.3M20.7M9.9M13.0M
Total Operating Expenses68.8M79.5M101.7M96.7M126.9M
Cost and Expenses212.6M167.0M194.1M172.0M198.2M
Operating Income (EBIT)12.6M(17.8M)(76.5M)(84.8M)(111.4M)
Non-Operating
Interest Income39.0M40.7M52.0M51.2M22.5M
Interest Expense————13.0K
Net Interest Income39.0M40.7M52.0M51.2M22.5M
Other Non-Op Income/Expense55.6M419.2K113.1M11.1M(9.6M)
Non-Operating Income (excl Interest)15.5M—(17.0M)(4.9M)(7.0M)
EBT (Pre-Tax Income)68.2M(17.4M)36.6M(73.7M)(121.0M)
Income Tax Expense(10.8M)(14.4M)(3.4M)(3.2M)34.2M
Bottom Line
Net Income69.8M(9.6M)41.1M(74.0M)(168.7M)
Earnings from Cont. Ops79.0M(3.0M)40.0M(70.4M)(155.2M)
Earnings from Discont. Ops———(4.1M)(13.6M)
Bottom Line Net Income69.8M(9.6M)41.1M(74.0M)(168.7M)
Per Share
Basic EPS$0.18($0.03)$0.11($0.19)($0.45)
Diluted EPS$0.18($0.03)$0.11($0.19)($0.45)
Revenue Per Share$0.58$0.39$0.31$0.23$0.23
Shares
Basic Shares Outstanding385.3M385.3M382.1M381.0M377.0M
Diluted Shares Outstanding385.3M385.3M385.6M381.0M377.0M
Profitability Metrics
EBITDA11.4M(3.4M)(50.2M)(71.8M)(91.3M)
D&A14.2M14.5M9.3M8.1M13.1M
EBIT(2.9M)(17.8M)(59.5M)(79.9M)(104.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026